Jefferies says Regeneron’s Dupixent drug could drive shares 15% higher
Regeneron's Dupixent drug could serve as the next big catalyst for shares of the pharmaceutical company, according to Jefferies.
Read more
Regeneron Pharmaceuticals Inc
Here are Monday’s biggest analyst calls: Tesla, Apple, Netflix, Amazon, UPS, Meta, Shopify & more
Here are the biggest calls on Wall Street on Source link
Read more
Pro Picks: Watch all of Friday’s big stock calls on CNBC
A recap of Friday's best stock picks on CNBC. Source link
Read more
Here are Friday’s biggest analyst calls: Netflix, Tesla, Apple, Coinbase, Tesla, Ralph Lauren & more
Here are the biggest calls on Wall Street on Source link
Read more
The market could be anticipating a Republican sweep of Congress in Tuesday’s election
Stocks that would benefit from Republican policies have been moving higher, signaling that traders anticipate the GOP will take both
Read more
The Fed could lay the groundwork for a year-end rally in the week ahead
Stocks are set to exit October with a tail wind but will soon face a Fed meeting that could help
Read more
Passage of Inflation Reduction Act gives Medicare historic new powers over drug prices
The legislation represents a historic expansion of Medicare's power that was fiercely opposed by the pharmaceutical industry. Source link
Read more
These names reporting earnings next week often beat estimates and trade higher
Not all companies will win big this season, but these names reporting earnings next week tend to beat analyst estimates
Read more
Goldman Sachs says a new investment cycle is coming — and names the stocks that could win
Goldman said a number of the stocks offer "reasonable value as well as attractive growth opportunities." Source link
Read more